Free Newsletter
| Get the pharma industry's daily monitor, with a special focus on pharmaceutical company news and the market development of FDA approved products. Sign up for free today! |
Diet center faker inflated Xenical sales
Roche's Xenical played a central role in the case of Robin Huxley, a U.K. operator of slimming clinics who pleaded guilty in December to violating prescription drug laws. Posing as a pharmacist--and using a pseudonym--Huxley bought more than $1 million worth of Xenical a month, accounting for most of Xenical's U.K. sales outside the National Health Service.
Roche stopped selling Xenical to Huxley when regulators launched an investigation in 2005. But court documents in a wrongful dismissal suit detail just how Roche amped up its sales to Huxley through discounts. Despite suspicions within the company and among analysts that Huxley wasn't completely kosher, the company helped Huxley buy another diet clinic, according to the Financial Times. Roche has since changed its distribution methods and won't sell meds to any private diet clinic directors.
- check out the Financial Times report
Related Articles:
Roche anticipates drop in Xenical sales. Report
FDA panel OKs OTC diet drug Xenical. Report
FDA expresses OTC Xenical doubts. Report
Comments
Post new comment
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness


